Association Between Use of Sodium–Glucose Cotransporter 2 Inhibitors and Epilepsy: A Population-Based Study Using Target Trial Emulation
SGLT-2is were associated with a reduced incidence of epilepsy in the study population. More studies are needed to confirm and replicate the study results.
Authors
- Hou-Yu Zhao (ORCID: https://orcid.org/0000-0002-4546-9342)
- Lin Zhuo (ORCID: https://orcid.org/0000-0001-9188-702X)
- Siyan Zhan (ORCID: https://orcid.org/0000-0001-7252-5349)
- Baixue Zhang
- Yueqi Yin (ORCID: https://orcid.org/0000-0003-1164-4074)
- Peng Shen (ORCID: https://orcid.org/0000-0002-0176-127X)
- Yexiang Sun (ORCID: https://orcid.org/0009-0006-2915-7521)
- Zhi-Qin Jiang
Institutions
- Chongqing University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Beijing Academy of Artificial Intelligence (CN)
- Peking University Third Hospital (CN)
- Guang’anmen Hospital (CN)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-03-25
- DOI
- https://doi.org/10.2337/dc24-2532
- Citations
- 4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.18